Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Chronic Spinal Cord Injury

NCT05725499 is registered in ClinicalTrials.gov with Kessler Foundation as lead sponsor.

NCT NCT05725499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05725499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Chronic Spinal Cord Injury
Lead sponsor
Kessler Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2023
Completion date
August 1, 2026
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, cardiovascular diseases, central nervous system diseases, hypotension, nervous system diseases, orthostatic hypotension, spinal cord diseases, spinal cord injuries, trauma, nervous system